BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6232561)

  • 21. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombophlebitis. A cardinal symptom of Behçet's syndrome.
    Haim S; Sobel JD; Friedman-Birnbaum R
    Acta Derm Venereol; 1974; 54(4):299-301. PubMed ID: 4137316
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behçet's disease and thrombophilia.
    Leiba M; Sidi Y; Gur H; Leiba A; Ehrenfeld M
    Ann Rheum Dis; 2001 Dec; 60(12):1081-5. PubMed ID: 11709446
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum zinc, copper and magnesium in Behçet's disease.
    Cengiz K; Gürkaynak F
    Mater Med Pol; 1988; 20(3):190-3. PubMed ID: 3244293
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemagglutination in Behcet's disease and other diseases. Its significance in diagnosis].
    UJIHARA S; KOGURE M
    Rinsho Ganka; 1962 Mar; 16():305-8. PubMed ID: 13923624
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
    Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
    Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma osteopontin levels in patients with Behcet's disease and psoriasis.
    Erturkler E; Cıcek D; Kaman D; Ozdogan S; Bakar Dertlıoglu S
    Eur J Dermatol; 2011; 21(2):203-8. PubMed ID: 21489910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
    Najim RA; Sharquie KE; Abu-Raghif AR
    J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory findings in Behcet's disease].
    Biyâl F; Sezer N; Hâtemi H; Altay L
    Turk Tip Cemiy Mecm; 1969 Oct; 35(10):603-8. PubMed ID: 4190922
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet's disease.
    Yapişlar H; Aydogan S; Borlu M; Ascioglu O
    Thromb Res; 2007; 119(4):461-5. PubMed ID: 16806408
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sialic acid value in Behcet's disease].
    Hatano M; Obara Y; Miyashita H; Sase Y
    Nihon Ganka Kiyo; 1971 Nov; 22(11):952-3. PubMed ID: 5169202
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma homocysteine level in patients with Behçet's disease.
    Balta I; Balta S; Ozturk C; Demirkol S
    Int J Rheum Dis; 2015 Jun; 18(5):582. PubMed ID: 25546109
    [No Abstract]   [Full Text] [Related]  

  • 40. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.